10-KPeriod: FY2019

QUEST DIAGNOSTICS INC Annual Report, Year Ended Dec 31, 2019

Filed February 20, 2020For Securities:DGX

Summary

Quest Diagnostics Incorporated, a leader in diagnostic information services, generated $7.7 billion in net revenues for 2019. The company's strategy is centered on accelerating growth through a two-pronged approach: expanding its portfolio of services (General Diagnostics, Advanced Diagnostics, and Diagnostic Services) and driving operational excellence. Key growth drivers include strategic acquisitions, partnerships with health plans and integrated delivery networks (IDNs), offering broad access to diagnostic innovation, focusing on a consumer-friendly experience, and leveraging data analytics for population health management. Quest Diagnostics emphasizes its strengths in quality, strong operating principles, extensive assets and capabilities, health information technology solutions, innovation, medical expertise, collaboration, and customer focus. The company is dedicated to enhancing operational efficiency through standardization, automation, and digitization to improve customer experience and strengthen its foundation for future growth. Significant investments are being made in optimizing the lab network, including a flagship laboratory under construction. The company also highlighted its commitment to disciplined capital deployment, including returning free cash flow to investors via dividends and share repurchases.

Financial Highlights

55 data points
Beta

Revenue

$7.73B

34.8% Gross Margin

Net Income

$858.00M

11.1% Net Margin

EPS (Diluted)

$6.28

Total Assets

$12.84B

Cash & Equivalents

$1.19B

Free Cash Flow

$843.00M

Financial Statements
Beta
Revenue$7.73B
Cost of Revenue$5.04B
Gross Profit$2.69B
SG&A Expenses$1.46B
Operating Expenses$6.50B
Operating Income$1.23B
Interest Expense$180.00M
Net Income$858.00M
EPS (Basic)$6.36
EPS (Diluted)$6.28
Shares Outstanding (Basic)134.00M
Shares Outstanding (Diluted)136.00M

Key Highlights

  • 1Quest Diagnostics reported $7.7 billion in net revenues for the fiscal year 2019.
  • 2The company's strategy focuses on accelerating growth through strategic acquisitions and organic growth drivers like partnerships, innovation, consumer focus, and data analytics.
  • 3Quest Diagnostics operates under a two-point strategy: Accelerate Growth and Drive Operational Excellence.
  • 4Key growth strategies include partnerships with health plans (e.g., UnitedHealthcare, Horizon BCBS NJ), IDNs, and expanding consumer-initiated testing (QuestDirect™).
  • 5The company emphasizes operational excellence through cost-saving programs like 'Invigorate' and investments in infrastructure, such as a new flagship laboratory.
  • 6Quest Diagnostics highlights its strengths in quality, innovation, customer focus, and extensive assets and capabilities, including the largest database of clinical lab results.
  • 7Disciplined capital deployment is a core principle, with a commitment to returning free cash flow to shareholders through dividends and share repurchases.

Frequently Asked Questions

Quest Diagnostics employs a two-point business strategy: 'Accelerate Growth' and 'Drive Operational Excellence.' Accelerating growth involves strategies like strategic acquisitions, partnering with health plans and IDNs, offering broad access to innovation, being a consumer-friendly choice, and supporting population health with data analytics. Driving operational excellence focuses on improving quality and efficiency across the value chain through standardization, automation, and digitization.

Quest Diagnostics aims to grow revenue through several avenues. This includes achieving a compound annual revenue growth rate of over 2% through accretive, strategic acquisitions. Additionally, they focus on organic growth by partnering with health plans and risk-bearing entities, offering the broadest access to diagnostic innovation, positioning themselves as a consumer-friendly provider, and supporting population health initiatives with data analytics and extended care services.

Key trends identified include PAMA-driven reimbursement pressure leading to rate reductions, health plans increasingly driving value in lab spending by favoring lower-cost providers, and 'consumerization' of healthcare where patients are more engaged and bear more financial responsibility. Other trends include the focus on prevention and wellness, medical innovation (especially in genomics and precision medicine), healthcare industry consolidation, and the increasing importance of pricing transparency.

Quest Diagnostics leverages several key strengths as competitive advantages. These include their quality of service, strong operating principles, extensive assets and capabilities (like a large data set, connectivity, logistics, and a broad network of patient access points), health information technology solutions, medical and scientific expertise, commitment to innovation, collaborative approach with partners, and a strong customer focus.